These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29529846)

  • 21. Cutaneous leishmaniasis in Switzerland: first experience with species-specific treatment.
    Mosimann V; Neumayr A; Hatz C; Blum JA
    Infection; 2013 Dec; 41(6):1177-82. PubMed ID: 23835701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Three Different Therapies for Cutaneous Leishmaniasis and Identification of the Etiologic Isolates in Isfahan, Iran.
    Abdellahi L; Hejazi SH; Amirmozafari N; Sotoodehnejadnematalahi F
    Arch Iran Med; 2020 Nov; 23(11):740-748. PubMed ID: 33220690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative histological and immunohistochemical changes of dry type cutaneous leishmaniasis after administration of meglumine antimoniate, imiquimod or combination therapy.
    Shamsi Meymandi S; Javadi A; Dabiri S; Shamsi Meymandi M; Nadji M
    Arch Iran Med; 2011 Jul; 14(4):238-43. PubMed ID: 21726098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse effects of intralesional meglumine antimoniate and its influence on clinical laboratory parameters in the treatment of cutaneous leishmaniasis.
    Esfandiarpour I; Farajzadeh S; Rahnama Z; Fathabadi EA; Heshmatkhah A
    Int J Dermatol; 2012 Oct; 51(10):1221-5. PubMed ID: 22994669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ongoing epidemic of cutaneous leishmaniasis among Syrian refugees, Lebanon.
    Saroufim M; Charafeddine K; Issa G; Khalifeh H; Habib RH; Berry A; Ghosn N; Rady A; Khalifeh I
    Emerg Infect Dis; 2014 Oct; 20(10):1712-5. PubMed ID: 25279543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An overview of a diagnostic and epidemiologic reappraisal of cutaneous leishmaniasis in Iran.
    Farahmand M; Nahrevanian H; Shirazi HA; Naeimi S; Farzanehnejad Z
    Braz J Infect Dis; 2011; 15(1):17-21. PubMed ID: 21412584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children.
    Layegh P; Pezeshkpoor F; Soruri AH; Naviafar P; Moghiman T
    Am J Trop Med Hyg; 2009 Feb; 80(2):172-5. PubMed ID: 19190206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for the expansion of cutaneous leishmaniasis by Leishmania tropica: Possible implications for control programmes.
    Gijón-Robles P; Abattouy N; Merino-Espinosa G; El Khalfaoui N; Morillas-Márquez F; Corpas-López V; Porcel-Rodríguez L; Jaaouani N; Díaz-Sáez V; Riyad M; Martín-Sánchez J
    Transbound Emerg Dis; 2018 Dec; 65(6):1615-1626. PubMed ID: 29806200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic diversity of Leishmania tropica strains isolated from clinical forms of cutaneous leishmaniasis in rural districts of Herat province, Western Afghanistan, based on ITS1-rDNA.
    Fakhar M; Pazoki Ghohe H; Rasooli SA; Karamian M; Mohib AS; Ziaei Hezarjaribi H; Pagheh AS; Ghatee MA
    Infect Genet Evol; 2016 Jul; 41():120-127. PubMed ID: 27063410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expansion of urban cutaneous leishmaniasis into rural areas of southeastern Iran: Clinical, epidemiological and phylogenetic profiles explored using 7SL high resolution melting-PCR analysis.
    Razavinasab SZ; Sharifi I; Aflatoonian MR; Babaei Z; Mohammadi MA; Salarkia E; Sharifi F; Aghaei Afshar A; Bamorovat M
    Transbound Emerg Dis; 2019 Jul; 66(4):1602-1610. PubMed ID: 30912874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran.
    Mohebali M; Fotouhi A; Hooshmand B; Zarei Z; Akhoundi B; Rahnema A; Razaghian AR; Kabir MJ; Nadim A
    Acta Trop; 2007 Jul; 103(1):33-40. PubMed ID: 17586452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergence of a new focus of anthroponotic cutaneous leishmaniasis due to Leishmania tropica in rural communities of Bam district after the earthquake, Iran.
    Sharifi I; Poursmaelian S; Aflatoonian MR; Ardakani RF; Mirzaei M; Fekri AR; Khamesipour A; Parizi MH; Harandi MF
    Trop Med Int Health; 2011 Apr; 16(4):510-3. PubMed ID: 21255206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in the Epidemiology of Cutaneous Leishmaniasis in Northeastern Iran.
    Farash BRH; Shamsian SAA; Mohajery M; Fata A; Sadabadi F; Berenji F; Mastroeni P; Poustchi E; Moghaddas E; Sangani GS; Farnoosh G
    Turkiye Parazitol Derg; 2020 Mar; 44(1):52-57. PubMed ID: 32212595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for therapeutic failure to meglumine antimoniate and miltefosine in adults and children with cutaneous leishmaniasis in Colombia: A cohort study.
    Castro MDM; Cossio A; Velasco C; Osorio L
    PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005515. PubMed ID: 28379954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic Meglumine Antimoniate in Cutaneous Leishmaniasis of Children: Clinical and Laboratory Complications.
    Layegh P; Khademi Z; Afzal Aghaee M; Moghiman T
    J Pediatric Infect Dis Soc; 2015 Dec; 4(4):356-8. PubMed ID: 26582874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiological study in a new focus of cutaneous leishmaniasis in the Islamic Republic of Iran.
    Yaghoobi-Ershadi MR; Akhavan AA; Zahraei-Ramazani AV; Abai MR; Ebrahimi B; Vafaei-Nezhad R; Hanafi-Bojd AA; Jafari R
    East Mediterr Health J; 2003 Jul; 9(4):816-26. PubMed ID: 15748078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The changing profile of cutaneous leishmaniasis in a focus of the disease in Jahrom district, southern Iran.
    Davami MH; Motazedian MH; Sarkari B
    Ann Trop Med Parasitol; 2010 Jul; 104(5):377-82. PubMed ID: 20819305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA-based detection of
    Kalantari M; Motazedian MH; Asgari Q; Soltani A; Mohammadpour I; Azizi K
    J Vector Borne Dis; 2020; 57(1):52-57. PubMed ID: 33818456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential expression of TLRs 2, 4, 9, iNOS and TNF-α and arginase activity in peripheral blood monocytes from glucantime unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis caused by Leishmania tropica.
    Oliaee RT; Sharifi I; Afgar A; Jafarzadeh A; Kareshk AT; Bamorovat M; Sharifi H; Babaei Z; Keyhani A; Keyhani A; Abedi L; Sharifi F
    Microb Pathog; 2019 Jan; 126():368-378. PubMed ID: 30399441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of cutaneous leishmaniasis in the State of Campeche (Yucatan Peninsula), Mexico, over a period of two years.
    Hernández-Rivera MP; Hernández-Montes O; Chiñas-Pérez A; Batiza-Avelar JM; Sánchez-Tejeda G; Wong-Ramírez C; Monroy-Ostria A
    Salud Publica Mex; 2015; 57(1):58-65. PubMed ID: 25629280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.